Inactive Instrument

Calendar Sonoma Pharmaceuticals Inc Nasdaq

Equities

US83558L1052

Chart calendar Sonoma Pharmaceuticals Inc

45338f00155c.q2FZfOkgqDsTWlkmTskGyg-vJ6pKxYizRaK3IXCVDDU.yiA1DpBjmHlBFDJlPrt-qCLbRtIEquLHaNP7dxKiYH3tLD8OuBWZUWdvMg~599d10e8c3cfd6416f08614e256a6cdd

Upcoming events on Sonoma Pharmaceuticals Inc

2024-08-13 Annual General Meeting
2024-11-10 Q2 2025 Earnings Release (Projected)
2025-02-17 Q3 2025 Earnings Release (Projected)
2025-07-08 Q4 2025 Earnings Release (Projected)

Past events on Sonoma Pharmaceuticals Inc

2024-06-17 05:00 pm Q4 2024 Earnings Release
2024-04-09 03:00 pm LD Micro Invitational Conference
2024-04-02 05:44 pm Trickle Research Spring Microcap Conference
2024-02-08 04:15 pm Q3 2024 Earnings Release
2023-11-13 04:30 pm Q2 2024 Earnings Release
2023-11-02 Symposium on Advanced Wound Care Fall Conference
2023-10-11 Dawson James Small Cap Growth Conference
2023-09-28 04:00 pm Annual General Meeting
2023-08-10 04:15 pm Q1 2024 Earnings Release
2023-06-22 07:30 am Q4 2023 Earnings Release
2023-02-14 04:30 pm Q3 2023 Earnings Release
2023-02-02 12:30 pm Sequire Biotechnology Conference
2022-11-14 04:15 pm Interim 2023 Earnings Release
2022-10-31 CPHI Conference
2022-09-15 04:00 pm Annual General Meeting
2022-08-11 04:30 pm Q1 2023 Earnings Release
2022-07-13 04:45 pm FY 2022 Earnings Release
2022-02-11 04:30 pm Q3 2022 Earnings Release
2022-01-09 H.C. Wainwright BioConnect Conference
2021-11-15 08:00 am Interim 2022 Earnings Release

Annual results

Fiscal PeriodMarch 2023 2024 2025
Net sales
Million USD
Released
Forecast
Spread
0,00


12,7
14,7
-13.37%

17,0

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-4,70
-4,61
-1.97%

-3,83

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-5,03
-5,08
0.96%

-3,99

Net income
Million USD
Released
Forecast
Spread
-5,15


-4,84
-5,08
4.82%

-3,99

EPS
USD
Released
Forecast
Spread
-1,52


-0,53
-0,89
40.45%

-0,20

Announcement Date21/06/2317/06/24-

Quarterly results

Fiscal PeriodMarch 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1
Net sales
Million USD
Released
Forecast
Spread



2,73
3,48
-21.52%
3,14
3,76
-16.54%
3,44
3,98
-13.59%

3,94


3,98


4,39


4,66


5,03

EBIT
Million USD
Released
Forecast
Spread



-1,21
-1,19
-1.51%
-0,84
-1,16
27.24%
-1,41
-1,02
-38.14%

-1,15


-0,95


-0,80


-0,93


-0,68

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-1,30
-1,28
-1.41%
-0,92
-1,25
26.16%
-1,36
-1,11
-22.43%

-1,19


-0,99


-0,84


-0,97


-0,72

Net income
Million USD
Released
Forecast
Spread
-1,42


-1,48
-1,28
-15.94%
-0,87
-1,25
30.72%
-1,07
-1,11
3.87%

-1,19


-0,99


-0,84


-0,97


-0,72

EPS
USD
Released
Forecast
Spread
-0,29


-0,29
-0,24
-20.83%
-0,08
-0,21
61.9%

-0,17


-0,06


-0,05


-0,04


-0,05


-0,03

Announcement Date10/08/2313/11/2308/02/2417/06/24-----
  1. Stock Market
  2. Equities
  3. SNOA Stock
  4. Stock
  5. Calendar Sonoma Pharmaceuticals Inc